Mirae Asset Global Etfs Holdings »

Cytomx Therapeutics shares owned by Mirae Asset Global Etfs Holdings

Quarter-by-quarter ownership of Cytomx Therapeutics (CTMX) shares owned by Mirae Asset Global Etfs Holdings from 13F filings

Historical chart of Mirae Asset Global Etfs Holdings investment in Cytomx Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Cytomx Therapeutics held by Mirae Asset Global Etfs Holdings consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cytomx Therapeutics by Mirae Asset Global Etfs Holdings

Quarter filed Position value Share count Share price at filing
2025-12-31 $66k 16k 4.16

More positions owned by Mirae Asset Global Etfs Holdings

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Global X Fds X Russell 2000 E (RSSL)
Cameco Corporation (CCJ)
Wheaton Precious Metals Corp (WPM)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Palantir Technologies Cl A (PLTR)
Broadcom (AVGO)
Tesla Motors (TSLA)
Meta Platforms Cl A (META)
Pan American Silver Corp Can (PAAS)
Oklo Com Cl A (OKLO)
Advanced Micro Devices (AMD)

View all positions for Mirae Asset Global Etfs Holdings

Top funds holding Cytomx Therapeutics

FMR
VR Adviser
Perceptive Advisors
Kynam Capital Management
Vanguard Group
Commodore Capital
Point72 Asset Management
State Street Corporation
Balyasny Asset Management
ADAR1 Capital Management
Baker Bros. Advisors
Financial Engines Advisors L.L.C
BlackRock
OrbiMed Advisors
Ikarian Capital

View all funds holding Cytomx Therapeutics